diff --git "a/66bf1f61-ed99-4c87-a7ec-ac236656f597.json" "b/66bf1f61-ed99-4c87-a7ec-ac236656f597.json" new file mode 100644--- /dev/null +++ "b/66bf1f61-ed99-4c87-a7ec-ac236656f597.json" @@ -0,0 +1,40 @@ +{ + "interaction_id": "66bf1f61-ed99-4c87-a7ec-ac236656f597", + "search_results": [ + { + "page_name": "ADAG | Adagene Inc. ADR Stock Price & News - WSJ", + "page_url": "https://www.wsj.com/market-data/quotes/ADAG", + "page_snippet": "", + "page_result": "\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n ADAG | Adagene Inc. ADR Stock Price & News - WSJ\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n if (window.__ace && typeof window.__ace === 'function') {\n const id = '61f2bdf7b00575078c959fee';\n const cb = () => {\n const vendorScript = document.createElement('script');\n vendorScript.src = 'https://d3icekm41k795y.cloudfront.net/rsxvmxxqlm.js';\n vendorScript.setAttribute('id', 'adtoniq');\n vendorScript.async = true;\n vendorScript.addEventListener('load', function () { window.__ace('page', 'setPerfMark', ['adtoniq-loaded']);window.__ace('adtoniq', 'initListener', ['154a3e38-2228-44d6-9db6-c9707f3647ea']); });\n document.body.appendChild(vendorScript);\n }\n __ace('djcmp', 'executeOnCmpReady', [{cb, id }]);\n };\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
\n \n
\n
\n
\n \n \n \n

Adagene Inc. ADR

ADAG (U.S.: Nasdaq)

NewsAdagene Inc. ADRADAG

No significant news for in the past two years.
Key Stock Data
P/E Ratio (TTM)
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period.
Earnings Per Share (TTM)
A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding.
Market Capitalization
Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple common share classes, market capitalization includes both classes.
Shares Outstanding
Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public.
Public Float
The number of shares in the hands of public investors and available to trade. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded.
Dividend Yield
A company's dividend expressed as a percentage of its current stock price.

Key Stock Data

  • P/E Ratio (TTM)
    N/A
  • EPS (TTM)
    $-0.87
  • Market Cap
    $141.87 M
  • Shares Outstanding
    43.77 M
  • Public Float
    37.33 M
  • Yield
    ADAG is not currently paying a regular dividend.
  • Latest Dividend
    N/A
  • Ex-Dividend Date
    N/A
Shares Sold Short
The total number of shares of a security that have been sold short and not yet repurchased.
Change from Last
Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.
Percent of Float
Total short positions relative to the number of shares available to trade.

Short Interest (02/15/24)

  • Shares Sold Short
    21,943
  • Change from Last
    -50.83%
  • Percent of Float
    0.06%
Money Flow Uptick/Downtick Ratio
Money flow measures the relative buying and selling pressure on a stock, based on the value of trades made on an "uptick" in price and the value of trades made on a "downtick" in price. The up/down ratio is calculated by dividing the value of uptick trades by the value of downtick trades. Net money flow is the value of uptick trades minus the value of downtick trades. Our calculations are based on comprehensive, delayed quotes.

Stock Money Flow

  • N/A

Research & Ratings Adagene Inc. ADR(ADAG)

Per-Share Earnings, Actuals and Estimates

Actual Analyst Range Consensus
\n
\n \n \n \n
Overview
\n

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock quotes are delayed as per exchange requirements. Fundamental company data and analyst estimates provided by FactSet. Copyright 2019\u00a9 FactSet Research Systems Inc. All rights reserved. Source: FactSet

\n

Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. Source: FactSet

\n

Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Sources: FactSet, Dow Jones

\n

Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones

\n

ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Sources: FactSet, Dow Jones

\n

Bonds: Bond quotes are updated in real-time. Sources: FactSet, Tullett Prebon

\n

Currencies: Currency quotes are updated in real-time. Sources: FactSet, Tullett Prebon

\n

Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Source: FactSet

\n \n

Data are provided 'as is' for informational purposes only and are not intended for trading purposes. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Data may be intentionally delayed pursuant to supplier requirements.

\n

Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright 2019\u00a9 Refinitiv. All rights reserved. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

\n

Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies)

\n

Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Source: Kantar Media

\n
\n \n \n \n \n\n \n \n \n \n \n \n \n \n \n\n\n \n \n ", + "page_last_modified": "" + }, + { + "page_name": "Adagene Inc. American Depositary Shares (ADAG) Stock Price, Quote, ...", + "page_url": "https://www.nasdaq.com/market-activity/stocks/adag", + "page_snippet": "", + "page_result": "\n\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n
\n\n \n \n\n \n \n \n \n \n \n \n\n \n \n \n \n\nSkip to main content\n\n
\n \n
\n\n
\n \n \n \n\n
\n \n
\n\n \n\n\n\n\n\n\n\n\n\n\n\n \n
\n\n
\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n
\n\n\n\n
\n
\n
\n
\n
\n\n\n \n\n \n \n
\n
\n
\n
\n \n
\n
\n
\n
\n
\n
\n \n \n
\n
\n\n\n
\n
\n \n \n
\n
\n\n\n
\n \n
\n
\n \n
\n \n \n\n
\n \n
\n \n When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.\n
\n
\n
\n\n
\n
\n \n \n
\n
\n\n\n
\n
\n \n \n
\n
\n\n\n
\n
\n\n
\n
\n
\n
\n\n\n\n
\n\n\n\n\n
\n
\n
\n \n
\n
\n
\n
\n
\n
\n\n
\n

\n Adagene Inc. American Depositary Shares (ADAG)\n

\n\n
\n \n
\n
\n\n
\n\n
\n
\n \n \n \n
\n \n \n \n
\n
\n \n
\n \n
\n
\n\n
\n
\n \n\n\n\n
\n
\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
\n
\n\n\n
Data is currently not available
\n \n
\n\n\n
\n \n \n \n
\n \n \n \n
\n
\n Bid:\n \n \n x \n \n
\n Ask:\n \n \n x \n \n
\n
\n Volume:\n \n
\n
\n \n
\n \n
\n
\n\n \n
\n
\n\n \n \n
\n
\n
\n \n
\n
\n
\n
\n
\n
\n \n \n \n \n \n
    \n
    \n
    \n\n
    \n
    \n \n
    \n
    \n \n
    \n
    \n\n
    \n\n
    \n
    \n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n
    \n
    \n
    \n
    \n
    \n\n\n\n
    \n\n\n
    \n
    \n
    \n
    \n \n \n \n \n \n\n
    \n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n
    \n
    \n\n\n
    \n\n
    \n
    \n
    \n \n \n
    \n\n
    \n\n
    \n
    \n\n
    \n \n
    \n\n
    \n \n
    \n
    \n
    \n \n
    \n \n \n \n \n \n \n \n \n \n
    \n \n
    \n
    \n\n\n
    \n
    \n\n
    \n
    \n \n\n\n\n
    \n
    \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
    \n
    \n\n\n
    Data is currently not available
    \n \n
    \n\n\n
    \n
    \n Previous
    Close
    \n  \n
    \n
    \n\n \n
    \n
    \n
    \n \n \n
    \n
    \n\n\n
    \n
    \n\n
    \n \n
    \n
    \n\n\n\n
    \n
    \n
    \n\n
    \n
    \n
    \n
    \n
    \n

    \n Key Data\n

    \n\n\n
    \n\n
    \n
    \n \n\n\n\n
    \n
    \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
    \n
    \n\n\n
    Data is currently not available
    \n \n
    \n\n\n \n \n \n \n \n \n \n \n \n \n \n \n
    LabelValue
    \n
    \n \n\n
    \n\n \n

    \n Bid Price and Ask Price\n

    \n \n
    \n \n \n \n

    \n The\u202fbid\u202f&\u202fask\u202frefers to the price that an investor is willing to buy or sell a stock. The\u202fbid\u202fis the highest amount that a buyer is currently willing to pay, whereas the ask\u202fis the lowest\n \n amount that a seller is currently willing to sell. The numbers next to the bid/ask are the \u201csize\u201d. The bid size displays the total amount of desired shares to buy at that price, and the ask size is the number of shares offered for sale at that price. The data displayed in the quote bar updates every 3 seconds; allowing you to monitor prices in real-time.

    \r\n\r\nThe\u202fbid-ask spread\u202fcan indicate a stock\u2019s liquidity, which is how easy it is to buy and sell in the marketplace. Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. In contrast, a larger spread suggests lower liquidity, as there are fewer investors willing to negotiate. You can use the bid-ask spread to determine whether to place a\u202f market order\u202for\u202flimit order\u202fwhen trading, helping you to optimize your price and have a successful order execution.

    \r\n\r\nReal-time bid and ask information is powered by Nasdaq Basic, a premier market data solution. This data feed is available via Nasdaq Data Link APIs; to learn more about subscribing, visit\u202fNasdaq Data Link's products page.
    \n \n

    \n
    \n \n \n \n \n \n \n \n \n \n \n \n \n \n
    LabelValue
    \n
    \n
    \n Powered by Nasdaq Data Link \n
    \n
    \n
    \n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n\n\n
    \n\n\n
    \n \n
    \n
    \n
    \n
    \n
    \n \n \n
    \n
    \n\n\n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n
    \r\n\n
    \n
    \n \n\n
    \n
    \n
    \n

    Analyze your stocks, your way

    \n
    \n

    Leverage the Nasdaq+ Scorecard to analyze stocks based on your investment priorities and our market data.

    \n
    \n \n
    \n
    \n
    \n
    \n\n\n
    \n
    \n
    \n \n
    \n
    \n
    \n \n\n\n\n
    \n
    \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
    \n
    \n\n\n
    Data is currently not available
    \n \n
    \n\n\n
    \n
    \n
    \n
    \n\n
    \n
    \n
    \n \n\n\n\n
    \n
    \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
    \n
    \n\n\n
    Data is currently not available
    \n \n
    \n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
    \n \n
    \n
    \n

    *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.

     \n

    **Green highlights the top performing ETF by % change in the past 100 days.

    \n
    \n
    \n
    \n
    \n\n\n\n\n
    \n
    \n
    \n
    \n\n
    \n
    \n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n
    \n
    \n

    \n News\n

    \n\n\n
    \n
    \n
    \n
    \n \n
    \n
    \n\n
    \n

    \n \n

    \n\n
    \n \n
    \n
    \n\n
    \n \n
    \n
    \n
    \n
    \n
    \n\n
    \n

    \n \n

    \n\n
    \n \n
    \n
    \n\n
    \n \n
    \n
    \n
    \n
    \n \n \n
    \n
    \n\n\n\n \n
    \n
    \n\n
    \n

    \n \n

    \n\n
    \n \n
    \n
    \n\n
    \n \n
    \n
    \n
    \n
    \n
    \n\n
    \n

    \n \n

    \n\n
    \n \n
    \n
    \n\n
    \n \n
    \n
    \n
    \n
    \n
    \n\n
    \n

    \n \n

    \n\n
    \n \n
    \n
    \n\n
    \n \n
    \n
    \n
    \n
    \n
    \n\n
    \n

    \n \n

    \n\n
    \n \n
    \n
    \n\n
    \n \n
    \n
    \n
    \n
    \n
    \n\n
    \n

    \n \n

    \n\n
    \n \n
    \n
    \n\n
    \n \n
    \n
    \n
    \n
    \n
    \n\n \n
    \n\n \n
    \n
    \n \n\n\n\n
    \n
    \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
    \n
    \n\n\n
    Data is currently not available
    \n \n
    \n\n\n
    \n
    \n

    About

    \n
    \n
    \n
    \n
    \n \n \n \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    Key Executives
    \n \n \n \n \n \n \n \n \n \n
    NameTitle
    \n
    \n \n
    \n \n
    \n\n\n\n\n
    \n
    \n
    \n

    \n Trending\n

    \n\n\n
    \n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n
    \n
    \n \n\n\n\n
    \n
    \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
    \n
    \n\n\n
    Data is currently not available
    \n \n
    \n\n\n
    \n
    \n
    \n \n \n \n \n \n

    \n
    \n \n \n \n \n
    \n
    \n\n\n
    \n
    \n
    \n\n
    \n\n
    \n\n\n
    \n
    \n \n
    \n
    \n
    \n
    \n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n
    \n
    \n \r\n
    \r\n \n
    \n
    \n\n
    \n
    \n
    \n
    • Real-time Data is provided using Nasdaq Last Sale Data
    • \n

    \u00a0

    \n\n

    Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at\u00a0data.nasdaq.com.

    \n\n
    \n
    \n
    \n\n\n\n\n
    \n\n \n
    \n\n \n \n
    \n \n\n
    \n \n
    \n
    \n \n
    \n
    \n
    \n
    \n \n View as Table\n
    \n
    \n
    now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.
    \n
    \n
    \n
    \n \n\n
    \n
    \n \n\n\n\n\n\n \n\n\n
    \n\n
    \n /\n
    \n\n
    \">\n \n\n\n\n\n\n \n\n\n
    \n
    \n\n\n
    \n \n
    \n
    \n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n \n \n
    \n
    \n\n\n\n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n \n Edit Watchlist\n
    \n
    \n
    \n Your Watchlist is empty.\n \n
    \n
    \n
    \n
    Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.
    \n
    \n
    \n
    \n \n\n
    \n
    \n \n\n\n\n\n\n \n\n\n
    \n\n
    \n /\n
    \n\n
    \">\n \n\n\n\n\n\n \n\n\n
    \n
    \n\n\n
    \n
      \n
    • \n \n \n \n

      \n

      \n \n \n

      \n
      \n
      \n
    • \n
      \n
      \n
      \n \n \n
      \n
      \n\n\n\n
      \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. Go to Smart Portfolio\n
    \n
    \n
    \n
    \n
    \n
    \n\n
    \n \n\n\n\n
    \n
    \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
    \n
    \n\n\n
    \n
    \n
    \n\n
    \n
    \n
    \n \n \n
    \n\n
    \n \n
    \n \n
    \n
    \n\n
    \n \n \n
    \n\n
    \n
    Most Active
    \n
      \n
    • \n \n \n \n
    • \n\n
      \n \n\n\n\n
      \n
      \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
      \n
      \n\n\n
      \n
      \n
      \n
      \n\n
      \n\n \n\n\n\n\n \n\n\n\n\n \n\n\n\n \n\n\n\n\n\n\n \n
      \n
      \n\n\n\n\n\n\n\n\n\n\n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n\n \n\n\n", + "page_last_modified": "" + }, + { + "page_name": "Adagene Inc. American Depositary Shares (ADAG) Stock Price, Quote, ...", + "page_url": "https://www.nasdaq.com/market-activity/stocks/adag", + "page_snippet": "", + "page_result": "\n\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n
      \n\n \n \n\n \n \n \n \n \n \n \n\n \n \n \n \n\nSkip to main content\n\n
      \n \n
      \n\n
      \n \n \n \n\n
      \n \n
      \n\n \n\n\n\n\n\n\n\n\n\n\n\n \n
      \n\n
      \n
      \n
      \n
      \n
      \n
      \n
      \n
      \n \n \n
      \n
      \n\n\n\n
      \n
      \n
      \n
      \n
      \n\n\n \n\n \n \n
      \n
      \n
      \n
      \n \n
      \n
      \n
      \n
      \n
      \n
      \n \n \n
      \n
      \n\n\n
      \n
      \n \n \n
      \n
      \n\n\n
      \n \n
      \n
      \n \n
      \n \n \n\n
      \n \n
      \n \n When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.\n
      \n
      \n
      \n\n
      \n
      \n \n \n
      \n
      \n\n\n
      \n
      \n \n \n
      \n
      \n\n\n
      \n
      \n\n
      \n
      \n
      \n
      \n\n\n\n
      \n\n\n\n\n
      \n
      \n
      \n \n
      \n
      \n
      \n
      \n
      \n
      \n\n
      \n

      \n Adagene Inc. American Depositary Shares (ADAG)\n

      \n\n
      \n \n
      \n
      \n\n
      \n\n
      \n
      \n \n \n \n
      \n \n \n \n
      \n
      \n \n
      \n \n
      \n
      \n\n
      \n
      \n \n\n\n\n
      \n
      \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
      \n
      \n\n\n
      Data is currently not available
      \n \n
      \n\n\n
      \n \n \n \n
      \n \n \n \n
      \n
      \n Bid:\n \n \n x \n \n
      \n Ask:\n \n \n x \n \n
      \n
      \n Volume:\n \n
      \n
      \n \n
      \n \n
      \n
      \n\n \n
      \n
      \n\n \n \n
      \n
      \n
      \n \n
      \n
      \n
      \n
      \n
      \n
      \n \n \n \n \n \n
        \n
        \n
        \n\n
        \n
        \n \n
        \n
        \n \n
        \n
        \n\n
        \n\n
        \n
        \n
        \n
        \n \n \n
        \n
        \n\n\n\n
        \n
        \n
        \n
        \n
        \n
        \n
        \n\n\n\n
        \n\n\n
        \n
        \n
        \n
        \n \n \n \n \n \n\n
        \n
        \n
        \n \n \n
        \n
        \n\n\n\n
        \n
        \n
        \n
        \n\n\n
        \n\n
        \n
        \n
        \n \n \n
        \n\n
        \n\n
        \n
        \n\n
        \n \n
        \n\n
        \n \n
        \n
        \n
        \n \n
        \n \n \n \n \n \n \n \n \n \n
        \n \n
        \n
        \n\n\n
        \n
        \n\n
        \n
        \n \n\n\n\n
        \n
        \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
        \n
        \n\n\n
        Data is currently not available
        \n \n
        \n\n\n
        \n
        \n Previous
        Close
        \n  \n
        \n
        \n\n \n
        \n
        \n
        \n \n \n
        \n
        \n\n\n
        \n
        \n\n
        \n \n
        \n
        \n\n\n\n
        \n
        \n
        \n\n
        \n
        \n
        \n
        \n
        \n

        \n Key Data\n

        \n\n\n
        \n\n
        \n
        \n \n\n\n\n
        \n
        \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
        \n
        \n\n\n
        Data is currently not available
        \n \n
        \n\n\n \n \n \n \n \n \n \n \n \n \n \n \n
        LabelValue
        \n
        \n \n\n
        \n\n \n

        \n Bid Price and Ask Price\n

        \n \n
        \n \n \n \n

        \n The\u202fbid\u202f&\u202fask\u202frefers to the price that an investor is willing to buy or sell a stock. The\u202fbid\u202fis the highest amount that a buyer is currently willing to pay, whereas the ask\u202fis the lowest\n \n amount that a seller is currently willing to sell. The numbers next to the bid/ask are the \u201csize\u201d. The bid size displays the total amount of desired shares to buy at that price, and the ask size is the number of shares offered for sale at that price. The data displayed in the quote bar updates every 3 seconds; allowing you to monitor prices in real-time.

        \r\n\r\nThe\u202fbid-ask spread\u202fcan indicate a stock\u2019s liquidity, which is how easy it is to buy and sell in the marketplace. Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. In contrast, a larger spread suggests lower liquidity, as there are fewer investors willing to negotiate. You can use the bid-ask spread to determine whether to place a\u202f market order\u202for\u202flimit order\u202fwhen trading, helping you to optimize your price and have a successful order execution.

        \r\n\r\nReal-time bid and ask information is powered by Nasdaq Basic, a premier market data solution. This data feed is available via Nasdaq Data Link APIs; to learn more about subscribing, visit\u202fNasdaq Data Link's products page.
        \n \n

        \n
        \n \n \n \n \n \n \n \n \n \n \n \n \n \n
        LabelValue
        \n
        \n
        \n Powered by Nasdaq Data Link \n
        \n
        \n
        \n
        \n
        \n \n \n
        \n
        \n\n\n\n
        \n
        \n\n\n
        \n\n\n
        \n \n
        \n
        \n
        \n
        \n
        \n \n \n
        \n
        \n\n\n
        \n
        \n \n \n
        \n
        \n\n\n\n
        \n
        \n
        \r\n\n
        \n
        \n \n\n
        \n
        \n
        \n

        Analyze your stocks, your way

        \n
        \n

        Leverage the Nasdaq+ Scorecard to analyze stocks based on your investment priorities and our market data.

        \n
        \n \n
        \n
        \n
        \n
        \n\n\n
        \n
        \n
        \n \n
        \n
        \n
        \n \n\n\n\n
        \n
        \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
        \n
        \n\n\n
        Data is currently not available
        \n \n
        \n\n\n
        \n
        \n
        \n
        \n\n
        \n
        \n
        \n \n\n\n\n
        \n
        \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
        \n
        \n\n\n
        Data is currently not available
        \n \n
        \n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
        \n \n
        \n
        \n

        *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.

         \n

        **Green highlights the top performing ETF by % change in the past 100 days.

        \n
        \n
        \n
        \n
        \n\n\n\n\n
        \n
        \n
        \n
        \n\n
        \n
        \n
        \n
        \n \n \n
        \n
        \n\n\n\n
        \n
        \n
        \n
        \n

        \n News\n

        \n\n\n
        \n
        \n
        \n
        \n \n
        \n
        \n\n
        \n

        \n \n

        \n\n
        \n \n
        \n
        \n\n
        \n \n
        \n
        \n
        \n
        \n
        \n\n
        \n

        \n \n

        \n\n
        \n \n
        \n
        \n\n
        \n \n
        \n
        \n
        \n
        \n \n \n
        \n
        \n\n\n\n \n
        \n
        \n\n
        \n

        \n \n

        \n\n
        \n \n
        \n
        \n\n
        \n \n
        \n
        \n
        \n
        \n
        \n\n
        \n

        \n \n

        \n\n
        \n \n
        \n
        \n\n
        \n \n
        \n
        \n
        \n
        \n
        \n\n
        \n

        \n \n

        \n\n
        \n \n
        \n
        \n\n
        \n \n
        \n
        \n
        \n
        \n
        \n\n
        \n

        \n \n

        \n\n
        \n \n
        \n
        \n\n
        \n \n
        \n
        \n
        \n
        \n
        \n\n
        \n

        \n \n

        \n\n
        \n \n
        \n
        \n\n
        \n \n
        \n
        \n
        \n
        \n
        \n\n \n
        \n\n \n
        \n
        \n \n\n\n\n
        \n
        \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
        \n
        \n\n\n
        Data is currently not available
        \n \n
        \n\n\n
        \n
        \n

        About

        \n
        \n
        \n
        \n
        \n \n \n \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        Key Executives
        \n \n \n \n \n \n \n \n \n \n
        NameTitle
        \n
        \n \n
        \n \n
        \n\n\n\n\n
        \n
        \n
        \n

        \n Trending\n

        \n\n\n
        \n
        \n
        \n \n \n
        \n
        \n\n\n\n
        \n
        \n \n \n
        \n
        \n\n\n\n
        \n
        \n
        \n
        \n \n\n\n\n
        \n
        \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
        \n
        \n\n\n
        Data is currently not available
        \n \n
        \n\n\n
        \n
        \n
        \n \n \n \n \n \n

        \n
        \n \n \n \n \n
        \n
        \n\n\n
        \n
        \n
        \n\n
        \n\n
        \n\n\n
        \n
        \n \n
        \n
        \n
        \n
        \n
        \n
        \n \n \n
        \n
        \n\n\n\n
        \n
        \n
        \n
        \n \r\n
        \r\n \n
        \n
        \n\n
        \n
        \n
        \n
        • Real-time Data is provided using Nasdaq Last Sale Data
        • \n

        \u00a0

        \n\n

        Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at\u00a0data.nasdaq.com.

        \n\n
        \n
        \n
        \n\n\n\n\n
        \n\n \n
        \n\n \n \n
        \n \n\n
        \n \n
        \n
        \n \n
        \n
        \n
        \n
        \n \n View as Table\n
        \n
        \n
        now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing Stocks, Funds, ETFs and more asset classes.
        \n
        \n
        \n
        \n \n\n
        \n
        \n \n\n\n\n\n\n \n\n\n
        \n\n
        \n /\n
        \n\n
        \">\n \n\n\n\n\n\n \n\n\n
        \n
        \n\n\n
        \n \n
        \n
        \n
        \n
        \n \n \n
        \n
        \n\n\n\n
        \n
        \n \n \n
        \n
        \n\n\n\n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n \n Edit Watchlist\n
        \n
        \n
        \n Your Watchlist is empty.\n \n
        \n
        \n
        \n
        Create your Watchlist to save your favorite quotes on Nasdaq.com. Log in or create a free account to get started.
        \n
        \n
        \n
        \n \n\n
        \n
        \n \n\n\n\n\n\n \n\n\n
        \n\n
        \n /\n
        \n\n
        \">\n \n\n\n\n\n\n \n\n\n
        \n
        \n\n\n
        \n
          \n
        • \n \n \n \n

          \n

          \n \n \n

          \n
          \n
          \n
        • \n
          \n
          \n
          \n \n \n
          \n
          \n\n\n\n
          \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n
        \n Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. Go to Smart Portfolio\n
        \n
        \n
        \n
        \n
        \n
        \n\n
        \n \n\n\n\n
        \n
        \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
        \n
        \n\n\n
        \n
        \n
        \n\n
        \n
        \n
        \n \n \n
        \n\n
        \n \n
        \n \n
        \n
        \n\n
        \n \n \n
        \n\n
        \n
        Most Active
        \n
          \n
        • \n \n \n \n
        • \n\n
          \n \n\n\n\n
          \n
          \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n
          \n
          \n\n\n
          \n
          \n
          \n
          \n\n
          \n\n \n\n\n\n\n \n\n\n\n\n \n\n\n\n \n\n\n\n\n\n\n \n
          \n
          \n\n\n\n\n\n\n\n\n\n\n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n\n \n\n\n", + "page_last_modified": "" + }, + { + "page_name": "ADAG Stock Price | Adagene Inc. ADR Stock Quote (U.S.: Nasdaq) ...", + "page_url": "https://www.marketwatch.com/investing/stock/adag", + "page_snippet": "ADAG | A complete ADAG overview by MarketWatch. View the latest market news and prices, and trading information.Shares of Adagene Inc. jumped 11.2% in premarket trading on Wednesday after it announced a licensing and commercialization deal with Sanofi that is worth up to $2.5 billion. U.S.-listed shares of Sanofi were down 1.5%. A...", + "page_result": "\n\n\n\n\n\n ADAG Stock Price | Adagene Inc. ADR Stock Quote (U.S.: Nasdaq) | MarketWatch\n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\r\n\r\n\r\n\r\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n\n\n \n\n \n\n\n\n\n\n\n\n\n \n\n\n \n \n \n \n \n \n \n\n\n\n\r\n\r\n
          \r\n \r\n
          \r\n\n\n
          \n\n\n
          \n
          \r\n
          \r\n \r\n \r\n
          \r\n
          \r\n
          \r\n\r\n\r\n
          \n\n\n \n\n
          \n\r\n\r\n
          \r\n\r\n\r\n
          \r\n\r\n\r\n
          \r\n\r\n\r\n\r\n\r\n\r\n
          \r\n
          \r\n \r\n
          \r\n
          \r\n
          \r\n
          \r\n
          \r\n\r\n\r\n
          \r\n\r\n\r\n\n\n\n
          \n
          \n
          \n \n \n
          \n
          \n S&P 500 Movers\n
          \n \n\n \n
          \n\n
          \n\n
          \n \n
          \n
          \n \n \n\r\n\r\n \n \n \n \n \n \n \n \r\n \n \n \n \n \n \n \n \r\n \n \n \n \n \n \n \n \r\n \n \n \n \n \n \n \n \r\n \n \n \n \n \n \n \n \r\n \n \n \n \n \n \n \n \r\n \n
          \n \n Dow\n 38,883.51\n \n -88.90\n \n -0.23%\n \n \n \n \n
          \n \n S&P 500\n 5,069.36\n \n -8.82\n \n -0.17%\n \n \n \n \n
          \n \n Nasdaq\n 15,956.44\n \n -78.86\n \n -0.49%\n \n \n \n \n
          \n \n VIX\n 13.58\n \n 0.15\n \n 1.12%\n \n \n \n \n
          \n \n Gold\n 2,042.40\n \n -1.70\n \n -0.08%\n \n \n \n \n
          \n \n Oil\n 79.11\n \n 0.24\n \n 0.30%\n \n \n \n \n
          \n
          \n
          \n
          \n
          \n
          \n
          \n\n \n\n
          \n
          \n
          \r\n
          \r\n
          \r\n
          \r\n\r\n\r\n
          \r\n\r\n\r\n\r\n\r\n
            \r\n
          1. \r\n \r\n Home\r\n \r\n \r\n
          2. \r\n
          3. \r\n \r\n Investing\r\n \r\n \r\n
          4. \r\n
          5. \r\n \r\n Quotes\r\n \r\n \r\n
          6. \r\n
          7. \r\n \r\n ADRs\r\n \r\n \r\n
          8. \r\n
          9. \r\n \r\n ADAG\r\n \r\n \r\n
          10. \r\n
          11. \r\n \r\n Overview\r\n \r\n \r\n
          12. \r\n
          \r\n\r\n\r\n \r\n
          \r\n
          \r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n \r\n
          \r\n
          \r\n
          \r\n \r\n \r\n
          \r\n
            \r\n
            \r\n \r\n |\r\n
            \r\n
            \r\n ADAG\r\n U.S.: Nasdaq\r\n
            \r\n \r\n\r\n\r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n

            Adagene Inc. ADR

            \r\n
            \r\n Watchlist \r\n\r\n
            \r\n \r\n \r\n
            \r\n
            \r\n NEW\r\n
            \r\n
            \r\n Set a price target alert\r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n
            \r\n \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n\r\n\r\n\r\n\r\n
            \r\n ADAGUS
            Open
            \r\n
            \r\n Last Updated: Feb 28, 2024 10:06 a.m. EST\r\n Delayed quote\r\n
            \r\n
            \r\n

            \r\n $\r\n 3.2600\r\n

            \r\n \r\n \r\n -0.0200\r\n -0.61%\r\n \r\n
            \r\n
            \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n
            Previous Close
            $3.2800
            \r\n
            \r\n
            \r\n\r\n\r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n\r\n\r\n\r\n\r\n \r\n \r\n
            \r\n
            \r\n
            \r\n \r\n \r\n
            \r\n Advanced Charting\r\n
            \r\n \r\n \r\n
            \r\n
            \r\n \r\n \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n\r\n\r\n\r\n\r\n \r\n
            \r\n Volume: 5.74K\r\n 65 Day Avg: 110.95K\r\n
            \r\n
            \r\n
            \r\n 5% vs Avg\r\n
            \r\n
            \r\n
            \r\n\r\n\r\n \r\n
            \r\n 3.2400\r\n Day Range\r\n 3.3550\r\n
            \r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n
            \r\n\r\n\r\n \r\n
            \r\n 1.1001\r\n 52 Week Range\r\n 4.3800\r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n \r\n
            \r\n\r\n\r\n
            \r\n\r\n\r\n\r\n\r\n\r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n\n
            \n
            \n

            \n Partner Center\n

            \n
            \n\r\n\r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n\r\n\r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n\r\n\r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n\r\n\r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n\r\n\r\n\r\n\r\n
            \r\n\r\n\r\n
            \r\n

            \r\n Your Watchlists\r\n

            \r\n
            \r\n\r\n\r\n\r\n\r\n
            \r\n
            \r\n
            Customize MarketWatch
            \r\n

            Have Watchlists? Log in to see them here or sign up to get started.

            \r\n
            \r\n
            \r\n Create Account\r\n … or Log In\r\n
            \r\n
            \r\n\r\n\r\n\r\n\r\n
            \r\n
            \r\n
            \r\n
            \r\n \r\n \r\n
            \r\n
            \r\n \r\n
            \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n
            \r\n
            Symbol
            \r\n Company\r\n
            \r\n
            Price
            \r\n Chg/Chg %\r\n
            \r\n \r\n \r\n
            \r\n\r\n\r\n
            \r\n
            \r\n
            \r\n
            No Items in Watchlist
            \r\n

            There are currently no items in this Watchlist.

            \r\n
            \r\n
            \r\n Add Tickers\r\n
            \r\n
            \r\n
            \r\n\r\n
            \r\n
            \r\n
            \r\n
            No Saved Watchlists
            \r\n

            Create a list of the investments you want to track.

            \r\n
            \r\n
            \r\n Create Watchlist\r\n …or learn more\r\n
            \r\n
            \r\n
            \r\n\r\n\r\n
            \r\n
            \r\n
            \r\n
            Uh oh
            \r\n

            Something went wrong while loading Watchlist.

            \r\n
            \r\n
            \r\n Go to Watchlist\r\n
            \r\n
            \r\n
            \r\n\r\n
            \r\n\r\n
            \r\n

            \r\n Recently Viewed Tickers\r\n

            \r\n
            \r\n\r\n
            \r\n
            \r\n
            \r\n

            No Recent Tickers

            \r\n

            Visit a quote page and your recently viewed tickers will be displayed here.

            \r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n\r\n\r\n\n\n
            \n
            \n\n\n
            \n
            \n
            \r\n \r\n
            \r\n\r\n\r\n\n\n
            \n

            \n ADAG Overview\n

            \n
            \n
            \r\n\r\n\r\n
            \r\n\r\n\r\n\n
            \n
            \n

            \n Key Data\n

            \n
            \n
              \n
            • \n Open\n $3.2400\n \n
            • \n
            • \n Day Range\n 3.2400 - 3.3550\n \n
            • \n
            • \n 52 Week Range\n 1.1001 - 4.3800\n \n
            • \n
            • \n Market Cap\n $141.87M\n \n
            • \n
            • \n Shares Outstanding\n 43.77M\n \n
            • \n
            • \n Public Float\n 37.33M\n \n
            • \n
            • \n Beta\n 0.37\n \n
            • \n
            • \n Rev. per Employee\n $91.29K\n \n
            • \n
            • \n P/E Ratio\n N/A\n \n
            • \n
            • \n EPS\n -$0.8692\n \n
            • \n
            • \n Yield\n N/A\n \n
            • \n
            • \n Dividend\n N/A\n \n
            • \n
            • \n Ex-Dividend Date\n N/A\n \n
            • \n
            • \n Short Interest\n 21.94K\n 02/15/24\n
            • \n
            • \n % of Float Shorted\n 0.06%\n \n
            • \n
            • \n Average Volume\n 110.95K\n \n
            • \n
            \n
            \n
            \r\n
            \r\n\r\n\r\n\r\n\r\n
            \r\n
            \r\n

            \r\n Performance\r\n

            \r\n
            \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n \r\n
            5 Day\r\n
              \r\n
            • 3.49%
            • \r\n
            • \r\n \r\n
            • \r\n
            \r\n
            1 Month\r\n
              \r\n
            • -10.93%
            • \r\n
            • \r\n \r\n
            • \r\n
            \r\n
            3 Month\r\n
              \r\n
            • 121.77%
            • \r\n
            • \r\n \r\n
            • \r\n
            \r\n
            YTD\r\n
              \r\n
            • 68.79%
            • \r\n
            • \r\n \r\n
            • \r\n
            \r\n
            1 Year\r\n
              \r\n
            • 80.11%
            • \r\n
            • \r\n \r\n
            • \r\n
            \r\n
            \r\n\r\n\r\n
            \r\n\r\n\r\n\r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n\n\n
            \n
            \n

            \n Analyst Ratings\n

            \n
            \n
            \n
              \n
            • Sell
            • \n
            • Under
            • \n
            • Hold
            • \n
            • Over
            • \n
            • Buy
            • \n
            \n Number of Ratings 2\n Full Ratings \n
            \n
            \n
            \r\n
            \r\n
            \r\n\r\n\r\n\r\n\r\n\r\n
            \r\n
            \r\n

            \r\n Recent News\r\n

            \r\n
            \r\n \r\n
            \r\n
              \r\n \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n\r\n\r\n\n\n \n \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n
            \n \n \n \n \n \n \n \n \n
            \n
            \n\n

            \n \n \n \n \n \n Sanofi to pay up to $2.5 billion in deal with Adagene\n \n

            \n

            Shares of Adagene Inc. jumped 11.2% in premarket trading on Wednesday after it announced a licensing and commercialization deal with Sanofi that is worth up to $2.5 billion. U.S.-listed shares of Sanofi were down 1.5%. A...

            \n\n \n\n
            \n Mar. 2, 2022 at 8:22 a.m. ET\n\n by Jaimy Lee\n \n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n
            \n \n \n \"Read\n \n \n \n \n \n
            \n
            \n\n

            \n \nIPOs \n \n \n \n \n 3 Chinese Companies Make Strong Market Debuts\n \n

            \n \n\n \n\n
            \n Feb. 9, 2021 at 5:18 p.m. ET\n\n by Barron's\n \n
            \n
            \n
            \n
            \n \n\n \n\n
            \n
            \n \n \n \n
            \r\n
            \r\n\r\n\r\n\n\n \n \n
            \n
            \n
            \n
            \n
            \n
            \n

            No Headlines Available

            \n
            \n
            \n \n \n \n
            \r\n
            \r\n
            \r\n
            \r\n\r\n\r\n\r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n\r\n\r\n\r\n
            \r\n \r\n
            \r\n
              \r\n \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n\r\n\r\n\n\n \n \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n Adagene Inc at HC Wainwright Investment Conference - New York Transcript\n \n

            \n

            Adagene Inc at HC Wainwright Investment Conference - New York Transcript

            \n\n \n\n
            \n Feb. 5, 2024 at 7:14 p.m. ET\n\n \n on GuruFocus.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n Adagene Inc at Morgan Stanley Global Healthcare Conference Transcript\n \n

            \n

            Adagene Inc at Morgan Stanley Global Healthcare Conference Transcript

            \n\n \n\n
            \n Feb. 5, 2024 at 7:14 p.m. ET\n\n \n on GuruFocus.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n Adagene Inc at EBD Group Biotech Showcase Transcript\n \n

            \n

            Adagene Inc at EBD Group Biotech Showcase Transcript

            \n\n \n\n
            \n Feb. 5, 2024 at 7:14 p.m. ET\n\n \n on GuruFocus.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n Adagene Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript\n \n

            \n

            Adagene Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

            \n\n \n\n
            \n Feb. 5, 2024 at 7:14 p.m. ET\n\n \n on GuruFocus.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n Adagene Inc at Jefferies China Biotech Summit (Virtual) Transcript\n \n

            \n

            Adagene Inc at Jefferies China Biotech Summit (Virtual) Transcript

            \n\n \n\n
            \n Feb. 5, 2024 at 7:14 p.m. ET\n\n \n on GuruFocus.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n 12 Health Care Stocks Moving In Thursday's After-Market Session\n \n

            \n

            \n\n \n\n
            \n Feb. 1, 2024 at 4:31 p.m. ET\n\n \n on Benzinga.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n 12 Health Care Stocks Moving In Monday's After-Market Session\n \n

            \n

            \n\n \n\n
            \n Jan. 22, 2024 at 4:31 p.m. ET\n\n \n on Benzinga.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session\n \n

            \n

            \n\n \n\n
            \n Jan. 19, 2024 at 1:05 p.m. ET\n\n \n on Benzinga.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n 12 Health Care Stocks Moving In Friday's Intraday Session\n \n

            \n

            \n\n \n\n
            \n Jan. 19, 2024 at 12:31 p.m. ET\n\n \n on Benzinga.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n 12 Health Care Stocks Moving In Thursday's Pre-Market Session\n \n

            \n

            \n\n \n\n
            \n Jan. 18, 2024 at 8:05 a.m. ET\n\n \n on Benzinga.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n How Is The Market Feeling About Adagene?\n \n

            \n

            \n\n \n\n
            \n Jan. 18, 2024 at 8:00 a.m. ET\n\n \n on Benzinga.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n 12 Health Care Stocks Moving In Wednesday's After-Market Session\n \n

            \n

            \n\n \n\n
            \n Jan. 17, 2024 at 4:31 p.m. ET\n\n \n on Benzinga.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n Why Airspan Networks Shares Are Trading Higher By Over 380%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session\n \n

            \n

            \n\n \n\n
            \n Jan. 17, 2024 at 1:12 p.m. ET\n\n \n on Benzinga.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n 12 Health Care Stocks Moving In Wednesday's Intraday Session\n \n

            \n

            \n\n \n\n
            \n Jan. 17, 2024 at 12:31 p.m. ET\n\n \n on Benzinga.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n Why Is Cancer Focused Adagene Stock Plummeting Today?\n \n

            \n

            \n\n \n\n
            \n Jan. 17, 2024 at 11:38 a.m. ET\n\n \n on Benzinga.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket\n \n

            \n

            \n\n \n\n
            \n Jan. 17, 2024 at 8:18 a.m. ET\n\n \n on Benzinga.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday\n \n

            \n

            \n\n \n\n
            \n Jan. 17, 2024 at 7:30 a.m. ET\n\n \n on InvestorPlace.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n Are Medical Stocks Lagging Boston Scientific (BSX) This Year?\n \n

            \n

            \n\n \n\n
            \n Oct. 30, 2023 at 9:40 a.m. ET\n\n \n on Zacks.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n Are Medical Stocks Lagging Medpace (MEDP) This Year?\n \n

            \n

            \n\n \n\n
            \n Oct. 13, 2023 at 9:40 a.m. ET\n\n \n on Zacks.com\n
            \n
            \n
            \n\r\n\r\n\r\n\n\n
            \n \n
            \n\n

            \n \n \n \n \n \n 12 Health Care Stocks Moving In Friday's Intraday Session\n \n

            \n

            \n\n \n\n
            \n Oct. 6, 2023 at 1:31 p.m. ET\n\n \n on Benzinga.com\n
            \n
            \n
            \n
            \n \n\n \n\n
            \n
            \n \n \n \n
            \r\n
            \r\n\r\n\r\n\n\n \n \n
            \n
            \n
            \n
            \n
            \n
            \n

            No Headlines Available

            \n
            \n
            \n \n \n \n
            \r\n
            \r\n
            \r\n
            \r\n \r\n \r\n
            \r\n
            \r\n\r\n\r\n
            \r\n\r\n\r\n\n\n
            \n
            \n

            \n Competitors\n

            \n
            \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
            NameChg %Market Cap
            Merck & Co. Inc.0.15%$326.48B
            AstraZeneca PLC ADR0.71%$203.07B
            AstraZeneca PLC-0.81%£160.1B
            Pfizer Inc.-1.07%$153.48B
            Bristol Myers Squibb Co.-0.02%$102.16B
            CStone Pharmaceuticals-3.03%HK$2.07B
            HBM Holdings Ltd.-2.48%HK$1.22B
            Alligator Bioscience AB3.30%kr718.49M
            Xilio Therapeutics Inc.4.17%$16.53M
            Bristol Myers Squibb Co. Rt14.66%
            \n
            \n
            \r\n \r\n
            \r\n
            \r\n
            \r\n\r\n\r\n
            \r\n\r\n\r\n\r\n\r\n\r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \n\n
            \n\n
            \n
            \n
            \n
            \n
            \n
            \n

            \n Advertisement\n

            \n
            \n
            \n
            \n
            \n\n
            \n
            \n
            \n

            \n Advertisement\n

            \n
            \n
            \n
            \n
            \n
            \n
            \n
            \n\n
            \n\n\n
            \n\r\n\r\n\r\n\r\n \r\n\r\n
            \n\n\n
            \n
            \n
            \n
            \n
            \n
            \n
            \n\n\n\n\n\n\n\n\n\n\r\n\r\n\r\n\r\n\r\n\r\n\r\n \n\r\n\r\n\r\n\r\n \n \n\r\n \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n

            Trending Tickers

            \r\n
            Above average volume.
            \r\n
            \r\n \r\n \r\n\r\n\r\n
            \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n \n \n\r\n\r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n \r\n \r\n \r\n \r\n
            \r\n \r\n
            \r\n
            \r\n Advanced Search\r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n\r\n\r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n\r\n
            \r\n
            \r\n
            \r\n

            \r\n Search Results\r\n

            \r\n
            \r\n
            \r\n
            \r\n\r\n
            \r\n
            \r\n\n\n
            \n
            \n

            Symbols

            \n
            Loading...
            \n \n \n \n
            \n
            \n
            \n \n \n\n\n
            \n
            \n

            Private Companies

            \n
            Loading...
            \n \n \n \n
            \n
            \n
            \n\r\n
            \r\n

            \r\n Recently Viewed Tickers\r\n

            \r\n
            \r\n\r\n
            \r\n
            \r\n
            \r\n

            No Recent Tickers

            \r\n

            Visit a quote page and your recently viewed tickers will be displayed here.

            \r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n\r\n\r\n\r\n
            \r\n \r\n
            \r\n
              \r\n \r\n \r\n \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n\r\n\r\n
            \r\n
            \r\n\r\n\r\n
            \r\n
            \r\n\r\n\r\n
            \r\n
            \r\n\r\n\r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n
            \r\n\r\n
            \r\n
            \r\n
            \r\n\n
            \n

            Authors

            \n
            \n
            \n\n\n\n\n\n
            \n

            Sections

            \n
            \n
            \n\n\n\n\n\n
            \n

            Columns

            \n
            \n
            \n\n\n\n\n
            \r\n
            \r\n
            \r\n\r\n
            \r\n\r\n
            \r\n
            \r\n\n
            \r\n
            \r\n
            \r\n
            \r\n \r\n
            \r\n

            \r\n Video Center\r\n

            \r\n
            \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n \r\n
            \r\n
            \r\n
            \r\n
            \r\n \n \n \n \n \n
            \n
            \n
            \n
            \n \n
            \n

            \n Time to Upgrade!\n

            \n
            \n
            \n
            \n
            \n

            This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser.

            \n
            \n \n
            \n
            \n
            \n
            \n \n \n \n\n \n \n \n\n\n", + "page_last_modified": "" + }, + { + "page_name": "Home - Adagene", + "page_url": "https://www.adagene.com/", + "page_snippet": "Adagene is a Nasdaq listed, global, clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer.Our core technology is built upon our fundamental understanding of the role that protein folding and the motion of molecules play in giving rise to dynamic conformational diversity, where an amino acid sequence can adopt multiple structures and functions. Adagene has created a platform composed of unique, multi-purpose, antibody technologies and a growing pipeline of leading assets with novel MOAs. Empowered by precision engineering, Adagene identifies and selects antibody candidates that are most likely to achieve the desired biological effects. Learn More | Adagene To Present Interim Results of Masked anti-CTLA-4 SAFEbody\u00ae ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at ASCO-GI Symposium | Adagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEbody\u00ae ADG126 at SITC 2023", + "page_result": "\n\n\n\n \n \n \n \n \n\n\n\nHome - Adagene\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\t\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\t\n\t\n\t\n\t\n\t\n\t\n\n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n
            \n Skip to content\n\n \"Adagene\"\n\n \n \n
            \n\n
            \n
            \n
            \n\n
            \n
            \n
            \n
            \n
            \n
            \n

            Redefining the design and discovery
            \nof therapeutic antibodies

            \n
            \n
            \n
            \n
            \n
            \n
            \n\n
            \n
            \n
            \n\n \n
            \n\t\n\t\n\t
            \n\t\t
            \n\t
            \n\t\t
            \n\t\t\t

            Dynamic and Adaptive Engagement

            \n\n\t\t
            \n\t
            \n\n\t
            \n\t\t
            \n\t\t\t

            Our core technology is built upon our fundamental understanding of the role that protein folding and the motion of molecules play in giving rise to dynamic conformational diversity, where an amino acid sequence can adopt multiple structures and functions. Adagene has created a platform composed of unique, multi-purpose, antibody technologies and a growing pipeline of leading assets with novel MOAs.

            \n

            Life is motion. The motion of proteins and their dynamic interactions trigger a cascade of complex biological and pharmacological effects.

            \n\n\t\t
            \n\t
            \n
            \n\t
            \n\t\t
            \n\t\t\t\n\t\t
            \n\t
            \n
            \n\t
            \n\t\t\n\t\t
            \n\t\t\t\"discovery\n\t\t
            \n\t
            \n
            \n\t
            \n\t\t
            \n\t\t\t

            Our Dynamic, Multi-Purpose Discovery Engine

            \n

            Empowered by precision engineering, Adagene identifies and selects antibody candidates that are most likely to achieve the desired biological effects.
            \nLearn More

            \n\n\t\t
            \n\t
            \n
            \n\t
            \n\t\t
            \n\t\t\t

            News & Events

            \n\n\t\t
            \n\t
            \n
            \n\t
            \n\t\t
            \n\t\t\t\n

            News

            \n\n\t\t
            \n\t
            \n\n\t
            \n\t\t
            \n\t\t\t

            More news

            \n\n\t\t
            \n\t
            \n
            \n\t
            \n\t\t
            \n\t\t\t

            Events

            \n\n\t\t
            \n\t
            \n\n\t
            \n\t\t
            \n\t\t\t
            \n
            \n
            \n
            \n
            \n\n
            2024.03.12 at 1:40 PM EDT
            \n
            \n
            \n
            \n\n\n\t\t
            \n\t
            \n
            \n\t
            \n\t\t\n\t\t
            \n\t\t\t\"Pipeline\"
            Pipeline
            \n\t\t
            \n\t
            \n
            \n\t
            \n\t\t\n\t\t
            \n\t\t\t\"Global
            Global Partnerships
            \n\t\t
            \n\t
            \n
            \n\t
            \n\t\t\n\t\t
            \n\t\t\t\"Careers\"
            Careers
            \n\t\t
            \n\t
            \n
            \n\t
            \n\t\t
            \n\t\t\t\n\t\t
            \n\t
            \n
            \n
            \t
            \n\n\t
            \n \n
            \n
            \n
            \n\n\n
            \n
            \n
            \n\n\n
            \n \n \n
            \n
            \n
            \n
            \n
            \n
            \n
            \n

            © 2024 Adagene

            \n
            \n
            \n
            \n
            \n
            \n
            \n
            \n
            \n
            \n
            \n \n
            \n\n \n\n\n\n\n \n \n\n \n\n\n \n\n\n\n\n\n\n\n", + "page_last_modified": "" + } + ] +} \ No newline at end of file